Vec­tor Bio­Med launch­es with $15M to pro­duce back­logged CAR-T com­po­nent

The man­u­fac­ture of lentivi­ral vec­tors has been grab­bing the at­ten­tion of in­vestors both small and large as of late, and an­oth­er man­u­fac­tur­er is look­ing to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER